Rimeporide: safety, tolerability and pharmacokinetic results from a phase Ib study in DMD boys as well as exploratory biomarkers
| Autor: | Stefano C. Previtali, J. Gray, N. Vidal, F. Porte-Thomé, J. Diaz, Jacqueline Pitchforth, J. Brimble, Teresa Gidaro, L. Servais, Maria Grazia Natali Sora, Alberto A. Zambon, C. Laveille, Simonetta Gerevini, Francesco Muntoni, D. Duchene, K. Groves, H. Gheit, V. Chê, K. Maresh, M. Annoussamy |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Oncology
medicine.medical_specialty business.industry Safety tolerability 030204 cardiovascular system & hematology 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Neurology Pharmacokinetics chemistry Internal medicine Pediatrics Perinatology and Child Health Rimeporide Medicine Neurology (clinical) business 030217 neurology & neurosurgery Genetics (clinical) |
| Zdroj: | Neuromuscular Disorders. 27:S215-S216 |
| ISSN: | 0960-8966 |
| DOI: | 10.1016/j.nmd.2017.06.438 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect